Work

CDC20 is a novel potential therapeutic target in NF1-mutant melanoma.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e22075

Authors: Douglas M. Donnelly, Keith M. Giles, Eleazar Vega-Saenz de Miera, Rebecca Betensky, Carolyn Winskill, Yu hsin Yeh, Iman Osman, George Jour

Institutions: New York University, NYU Langone Health

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3031537638

Cites:

Cited by:

Related to: 10